A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Phendimetrazine
Gluconic Acid
The risk or severity of adverse effects can be increased when Potassium is combined with Gluconic Acid.
Phendimetrazine
Plecanatide
The risk or severity of adverse effects can be increased when Potassium is combined with Plecanatide.
Phendimetrazine
Lactitol
The risk or severity of adverse effects can be increased when Potassium is combined with Lactitol.
Phendimetrazine
Sennosides
The risk or severity of adverse effects can be increased when Potassium is combined with Sennosides.
Phendimetrazine
Methylcellulose
The risk or severity of adverse effects can be increased when Potassium is combined with Methylcellulose.
Phendimetrazine
Magnesium glycinate
The risk or severity of adverse effects can be increased when Potassium is combined with Magnesium glycinate.
Phendimetrazine
Castor oil
The risk or severity of adverse effects can be increased when Potassium is combined with Castor oil.
Phendimetrazine
Magnesium citrate
The risk or severity of adverse effects can be increased when Potassium is combined with Magnesium citrate.
Phendimetrazine
Plantago seed
The risk or severity of adverse effects can be increased when Potassium is combined with Plantago seed.
Phendimetrazine
Docusate
The risk or severity of adverse effects can be increased when Potassium is combined with Docusate.
Phendimetrazine
Carboxymethylcellulose
The risk or severity of adverse effects can be increased when Potassium is combined with Carboxymethylcellulose.
Phendimetrazine
Mineral oil
The risk or severity of adverse effects can be increased when Potassium is combined with Mineral oil.
Phendimetrazine
Sodium fluorophosphate
The risk or severity of adverse effects can be increased when Potassium is combined with Sodium fluorophosphate.
Phendimetrazine
Potassium lactate
The risk or severity of adverse effects can be increased when Potassium is combined with Potassium lactate.
Phendimetrazine
Dipotassium phosphate
The risk or severity of adverse effects can be increased when Potassium is combined with Dipotassium phosphate.
Phendimetrazine
Monopotassium phosphate
The risk or severity of adverse effects can be increased when Potassium is combined with Monopotassium phosphate.
Phendimetrazine
Magnesium acetate tetrahydrate
The risk or severity of adverse effects can be increased when Potassium is combined with Magnesium acetate tetrahydrate.
Phendimetrazine
Polycarbophil
The risk or severity of adverse effects can be increased when Potassium is combined with Polycarbophil.
Phendimetrazine
Magnesium trisilicate
The risk or severity of adverse effects can be increased when Potassium is combined with Magnesium trisilicate.
Phendimetrazine
Picosulfuric acid
The risk or severity of adverse effects can be increased when Potassium is combined with Picosulfuric acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3